Thomas Flaten
Stock Analyst at Lake Street
(0)
# 4269
Out of 5,218 analysts
35
Total ratings
33.33%
Success rate
-7.56%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Castle Biosciences | Maintains: Strong Buy | 34 40 | 28.83 | 38.74% | 5 | Nov 5, 2024 | |
Journey Medical | Initiates Coverage On: Buy | 9 | 5.12 | 75.78% | 1 | Sep 6, 2024 | |
OptiNose | Maintains: Buy | 4 3 | 0.47 | 538.3% | 3 | May 15, 2024 | |
Personalis | Initiates Coverage On: Buy | 4 | 3.84 | 4.17% | 1 | Apr 30, 2024 | |
DermTech | Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.92 | 226.09% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 8 | 3.63 | 120.39% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 4.09 | 168.95% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 3.67 | 281.47% | 3 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 26.67 | -6.26% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 180 70 | 1.15 | 5986.96% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 10 | 2.34 | 327.35% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 5.65 | 25386.73% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 5.43 | 47.33% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |